ClinicalTrials.gg
Biological

Escherichia coli clinical trials

studies test it
17
open now
2
in phase 3
3
first study started
2014

How each study uses Escherichia coli is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Escherichia coli studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Recombinant Nonavalent (types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia coli)
5
Recombinant Hepatitis E Vaccine (Escherichia Coli)
4
Hecolin®
4
Escherichia coli
1

Studies by the year they started

17 studies that test it; most in 2020 (3)

Studies that test Escherichia coli, by start year
YearStudies
20141
20152
20161
20171
20181
20192
20203
20221
20233
20242

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
2
Phase 3
3
Phase 4
7
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 12 · Other 5

Xiamen Innovax Biotech Co., Ltd (6) · Beijing Health Guard Biotechnology, Inc (5) · University Hospital, Linkoeping (1) · Jiangsu Province Centers for Disease Control and Prevention (1) · Jun Zhang (1) · NIZO Food Research (1) · International Vaccine Institute (1) · Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (1)

Studies

Open first, then newest update. How each study uses Escherichia coli is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Given beside what is tested · 1 — Escherichia coli is usual care or a partner of the new treatment

Codes

What other systems call Escherichia coli · ClinicalTrials.gg INT014965

  • UNII (FDA) 514B9K0L10ESCHERICHIA COLIConfirmed FDA, Wikidata
  • RxNorm 350202One source FDA
  • Wikidata Q25419Escherichia coliConfirmed FDA, Wikidata
  • NCI Thesaurus C14206Escherichia coliOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.